Magnus Olafsson Corfitzen

Magnus Olafsson Corfitzen

Chief Executive Officer bij ASCELIA PHARMA AB

Vermogen: 275 323 $ op 31-03-2024

49 jaar
Health Technology
Finance
Commercial Services

Profiel

Mr. Magnus Olafsson Corfitzen is a Chief Executive Officer at Ascelia Pharma AB.
He is on the Board of Directors at Ascelia Incentive AB and Inventive AB.
Mr. Corfitzen was previously employed as an Investment Director by Sunstone Capital A/S, a Chief Executive Officer by CMC Contrast AB, an Investment Director by Danmarks Eksport- og Investeringsfond, a Portfolio Manager by Danske Bank A/S (Investment Management), a Portfolio Manager by Danske Capital AB, a Chairman by FBC Device ApS, a Principal by McKinsey & Co., Inc., and a Chief Executive Officer by Oncoral Pharma ApS.
He also served on the board at Vivostat A/S, Aro Medical ApS, DentoFit A/S, Nordic Vaccine A/S and Opsona Therapeutics Ltd.
He received his graduate degree from the University of Aarhus.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
17-07-2023 319 645 ( 0.95% ) 275 323 $ 31-03-2024

Actieve functies van Magnus Olafsson Corfitzen

BedrijvenFunctieBegin
ASCELIA PHARMA AB Chief Executive Officer 01-01-2014
Inventive AB Director/Board Member -
Ascelia Incentive AB Director/Board Member -
Alle actieve functies van Magnus Olafsson Corfitzen

Eerdere bekende functies van Magnus Olafsson Corfitzen

BedrijvenFunctieEinde
Director of Investments 30-06-2014
Director/Board Member 27-01-2014
Chief Executive Officer -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Magnus Olafsson Corfitzen in detail bekijken

Opleiding van Magnus Olafsson Corfitzen

University of Aarhus Graduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Magnus Olafsson Corfitzen in detail bekijken

Connecties

63

Eerstegraads connecties

17

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
ASCELIA PHARMA AB

Health Technology

Bedrijven in privébezit15

Health Technology

Commercial Services

Finance

Finance

Finance

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Ascelia Incentive AB

Inventive AB

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Magnus Olafsson Corfitzen